Voluntary Recall of Chariot™ Guiding Sheath

09 Dec, 2015, 16:30 ET from Boston Scientific

MARLBOROUGH, Mass., Dec. 9, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has voluntarily recalled the Chariot Guiding Sheath globally. These devices are intended for the introduction of interventional devices during peripheral vascular procedures, and were recalled on November 19th due to the risk of shaft separation. The U.S. Food and Drug Administration (FDA) has classified the action as a Class-1 recall.

To date, Boston Scientific has received fourteen complaints for shaft separation, four of which involved separation of the distal shaft.  These events occurred during device preparation or use. The most severe outcome of this failure is embolism of device fragments, which could lead to obstruction of blood flow or additional intervention to remove a device fragment.  Obstruction of blood flow can result in injuries such as stroke, kidney damage or damage to the intestines or limbs. To date, no permanent injuries or patient deaths have been reported.

All affected healthcare facilities were previously advised to immediately discontinue use of affected devices and return unused Chariot Guiding Sheaths to Boston Scientific.  Additionally, physicians are encouraged to contact all patients who have undergone procedures involving Chariot to confirm their post-procedure status, as device shaft separation and embolized fragments may not have been recognized at the time of the procedure.

The recall affects all UPNs of the Chariot Guiding Sheaths. Customers have been advised to remove the affected recalled product from inventory and return it to Boston Scientific.

 

H74939277645110

H74939277745110

H74939277845110

H74939277645220

H74939277765120

H74939277690210

H74939277665110

H74939277790110

H74939277645120

H74939277865120

H74939277690220

H74939277690110

H74939277865110

H74939277745120

H74939277890120

H74939277845210

H74939277765110

H74939277545210

H74939277790210

H74939277845120

H74939277745210

H74939277545110

H74939277790220

H74939277790120

H74939277745220

H74939277645210

H74939277690120

H74939277665120

H74939277890110

 

Physicians and healthcare facilities can direct questions to their Boston Scientific representative or by calling 1-800-811-3211. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

or

  • Health care professionals and consumers may report serious adverse events or product quality problems with the use of this product to Boston Scientific by calling 1-800-811-3211 and to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or phone.

CONTACT:  Tom Keppeler Corporate Communications Boston Scientific Corporation +1 (508) 683-6585 Thomas.Keppeler@bsci.com

Susie Lisa, CFA Investor Relations Boston Scientific Corporation +1 (508) 683-5565 investor_relations@bsci.com

SOURCE Boston Scientific